In our previous studies, proteins from the Ly6 family, LY6D, have been identified to be upregulated in colon CSCs, where they are implicated in tumor progression and CSC maintenance, while research on LY6K in colon CSCs is limited [16]. This evidence concerns the gene LY6K and neoplasm.